ISSN: 1745-8552

Journal Home

Journal Guideline

BioSocieties Q3 Unclaimed

Palgrave Macmillan Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

BioSocieties is a journal indexed in SJR in Health (social science) and Health Policy with an H index of 31. It has a price of 2290 €. It has an SJR impact factor of 0,403 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,403.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Health Policy (Q3) Health (social science) (Q3)

Price

2290 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,403

SJR Impact factor

31

H Index

61

Total Docs (Last Year)

82

Total Docs (3 years)

4645

Total Refs

135

Total Cites (3 years)

74

Citable Docs (3 years)

1.54

Cites/Doc (2 years)

76.15

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

HEC Forum Q3
Sahara J Q3
Cambridge Quarterly of Healthcare Ethics Q3
Journal of Social Work in End-of-Life and Palliative Care Q3
American Journal of Health Education Q3

Compare this journals

Aims and Scope

Best articles by citations

Editorial

Clones and critics in the age of biocapital

Ambiguous Mutations: Breast Cancer Genetics and the Quest for Meaningful Molecular Medicine

An Austrian Perspective

Pathways to Plausibility: When Herbs Become Pills

The Many Meanings of the Placebo Effect: Where They Came From, Why They Matter

Integrating Social Science with Neuroscience: Potentials and Problems

Civilizing technologies' and the control of deviance

The Changing Nature of Ideology in the Life Sciences in Mainland China: Case-studies of Human Cloning and Human Embryonic Stem Cell Research (hESR) in Medical Textbooks (1996-2005)

Socio-technical disagreements as ethical fora: Parabon NanoLab's forensic DNA Snapshot‚Ñ¢ service at the intersection of discourses around robust science, technology validation, and commerce

I'm not Really Read up on Genetics': Biobanks and the Social Context of Informed Consent

Cornering the Futures Market in 'Bio-epistemology'

SHOW MORE ARTICLES

Second thoughts on the prevalence of enhancement

Somatographic Investigations Across Levels of Complexity

Model homes for model organisms: Intersections of animal welfare and behavioral neuroscience around the environment of the laboratory mouse

Race, Risk and Medicine in the Age of 'Your Own Personal Genome'

Too Much Ownership: Bio-prospecting in the Age of Synthetic Biology

Maurice Seevers, the stimulants and the political economy of addiction in American biomedicine

A Norwegian Perspective

Making up families: how DNA analysis does/does not verify relatedness in family reunification in Finland

Going stolon

Drugs, addiction and society

The debate on neuro-enhancement: What can bioethics learn from the history of amphetamine use?

HIV and the remaking of hunger and nutrition in South Africa: Biopolitical specification after apartheid